FTY720-induced suicidal erythrocyte death

Cellular Physiology and Biochemistry

Volumn 26, Issue 4-5, 2010, Pages 761-766

  Eberhard, Matthias ^a   Ferlinz, Klaus ^a   Alizzi, Katia ^b   Cacciato, Patrizia Maria ^b   Faggio, Caterina ^b   Föller, Michael ^a   Lang, Florian ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b Section of General Physiology and Pharmacology   (Italy)

Author keywords

Apoptosis; Calcium; Cell volume; Eryptosis; Phosphatidylserine; Scrambling

Indexed keywords

CALCIUM ION; CERAMIDE; FINGOLIMOD; HEMOGLOBIN; LIPOCORTIN 5;

ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CELL DEATH; CELL MEMBRANE; CYTOSOL; DRUG CYTOTOXICITY; ERYTHROCYTE; EXTRACELLULAR CALCIUM; FLUORESCENCE; FLUORESCENCE ACTIVATED CELL SORTING; HEMOLYSIS; IN VITRO STUDY; PRIORITY JOURNAL;

EID: 78149442081     PISSN: 10158987     EISSN: None     Source Type: Journal    
DOI: 10.1159/000322343     Document Type: Article

References (52)

1. Van Der Giet M, Tolle M, Kleuser B: Relevance and potential of sphingosine-1-phosphate in vascular inflammatory disease. Biol Chem 2008;389:1381-1390.
2. Wenderfer SE, Stepkowski SM, Braun MC: Increased survival and reduced renal injury in MRL/lpr mice treated with a novel sphingosine-1-phosphate receptor agonist. Kidney Int 2008;74:1319-1326.
3. Zhang Z, Fauser U, Schluesener HJ: Early attenuation of lesional interleukin-16 up-regulation by dexamethasone and FTY720 in experimental traumatic brain injury. Neuropathol Appl Neurobiol 2008;34:330-339.
4. Kihara A, Igarashi Y: Production and release of sphingosine 1-phosphate and the phosphorylated form of the immunomodulator FTY720. Biochim Biophys Acta 2008;1781:496-502.
5. Anada Y, Igarashi Y, Kihara A: The immunomodulator FTY720 is phospho-rylated and released from platelets. Eur J Pharmacol 2007;568:106-111.
6. Hung JH, Lu YS, Wang YC, Ma YH, Wang DS, Kulp SK, Muthusamy N, Byrd JC, Cheng AL, Chen CS: FTY720 induces apoptosis in hepatocellular carcinoma cells through activation of protein ki-nase C delta signaling. Cancer Res 2008;68:1204-1212.
7. Sugito K, Inoue M, Ikeda T, Hagiwara N, Koshinaga T, Kusafuka T: Effect of FTY720 and ex vivo graft irradiation in rat small bowel transplantation: apoptosis of crypt cells and lymphocytes. Transplant Proc 2007;39:3432-3435.
8. Sun E, Zhang L, Zeng Y, Ge Q, Zhao M, Gao W: Apoptotic cells actively inhibit the expression of CD69 on Con A activated T lymphocytes. Scand J Immunol 2000;51:231-236.
9. Bohler T, Guillebaud J, Etienne L, Canivet C, Kamar N, Rostaing L, Thiers JC, Galvani S, Auge N, Salvayre R, Negre-Salvayre A, Thomsen M: Effect of FTY720 on apoptosis of smooth muscle cells. Transplant Proc 2007;39:2624-2626.
10. Coelho RP, Payne SG, Bittman R, Spiegel S, Sato-Bigbee C: The immunomodulator FTY720 has a direct cytoprotective effect in oligodendrocyte progenitors. J Pharmacol Exp Ther 2007;323:626-635.
11. Lang F, Gulbins E, Lerche H, Huber SM, Kempe DS, Föller M: Eryptosis, a window to systemic disease. Cell Physiol Biochem 2008;22:373-380.
12. Berg CP, Engels IH, Rothbart A, Lauber K, Renz A, Schlosser SF, Schulze-Osthoff K, Wesselborg S: Human mature red blood cells express caspase-3 and caspase-8, but are devoid of mitochondrial regulators of apoptosis. Cell Death Differ 2001;8:1197-1206.
13. Bratosin D, Estaquier J, Petit F, Arnoult D, Quatannens B, Tissier JP, Slomianny C, Sartiaux C, Alonso C, Huart JJ, Montreuil J, Ameisen JC: Programmed cell death in mature erythrocytes: a model for investigating death effector pathways operating in the absence of mitochondria. Cell Death Differ 2001;8:1143-1156.
14. Lang KS, Duranton C, Poehlmann H, Myssina S, Bauer C, Lang F, Wieder T, Huber SM: Cation channels trigger apoptotic death of erythrocytes. Cell Death Differ 2003;10:249-256.
15. Bookchin RM, Ortiz OE, Lew VL: Activation of calcium-dependent potassium channels in deoxygenated sickled red cells. Prog Clin Biol Res 1987;240:193-200.
16. Brugnara C, de Franceschi L, Alper SL: Inhibition of Ca(2+)-dependent K+ transport and cell dehydration in sickle eryth-rocytes by clotrimazole and other imi-dazole derivatives. J Clin Invest 1993;92:520-526.
17. Lang PA, Kaiser S, Myssina S, Wieder T, Lang F, Huber SM: Role of Ca2+-acti-vated K+ channels in human erythro-cyte apoptosis. Am J Physiol Cell Physiol 2003;285:C1553-C1560.
18. Duranton C, Huber SM, Lang F: Oxidation induces a Cl(-)-dependent cation conductance in human red blood cells. J Physiol 2002;539:847-855.
19. Huber SM, Gamper N, Lang F: Chloride conductance and volume-regulatory non-selective cation conductance in human red blood cell ghosts. Pflugers Arch 2001;441:551-558.
20. Foller M, Kasinathan RS, Koka S, Lang C, Shumilina E, Birnbaumer L, Lang F, Huber SM: TRPC6 contributes to the Ca(2+) leak of human erythrocytes. Cell Physiol Biochem 2008;21:183-192.
21. Lang KS, Myssina S, Brand V, Sandu C, Lang PA, Berchtold S, Huber SM, Lang F, Wieder T: Involvement of ceramide in hyperosmotic shock-induced death of erythrocytes. Cell Death Differ 2004;11:231-243.
22. Foller M, Feil S, Ghoreschi K, Koka S, Gerling A, Thunemann M, Hofmann F, Schuler B, Vogel J, Pichler B, Kasinathan RS, Nicolay JP, Huber SM, Lang F, Feil R: Anemia and splenomegaly in cGKI-deficient mice. Proc Natl Acad Sci \USA 2008;105:6771-6776.
23. Foller M, Sopjani M, Koka S, Gu S, Mahmud H, Wang K, Floride E, Schleicher E, Schulz E, Munzel T, Lang F: Regulation of erythrocyte survival by AMP-activated protein kinase. FASEB J 2009;23:1072-1080.
24. Brand VB, Sandu CD, Duranton C, Tanneur V, Lang KS, Huber SM, Lang F: Dependence of Plasmodium falciparum in vitro growth on the cation permeability of the human host erythrocyte. Cell Physiol Biochem 2003;13:347-356.
25. Daugas E, Cande C, Kroemer G: Eryth-rocytes: death of a mummy. Cell Death Differ 2001;8:1131-1133.
26. Klarl BA, Lang PA, Kempe DS, Niemoeller OM, Akel A, Sobiesiak M, Eisele K, Podolski M, Huber SM, Wieder T, Lang F: Protein kinase C mediates erythrocyte "programmed cell death" following glucose depletion. Am J Physiol Cell Physiol 2006;290:C244-C253. 27
27. Liu Q, Zhao X, Frissora F, Ma Y, Santhanam R, Jarjoura D, Lehman A, Perrotti D, Chen CS, Dalton JT, Muthusamy N, Byrd JC: FTY720 demonstrates promising preclinical activity for chronic lymphocytic leukemia and lymphoblastic leukemia/lymphoma. Blood 2008;111:275-284.
28. Meno-Tetang GM, Lowe PJ: On the pre-diction of the human response: a recycled mechanistic pharmacokinetic/phar-macodynamic approach. Basic Clin Pharmacol Toxicol 2005;96:182-192.
29. Kovarik JM, Schmouder RL, Serra D, Wang Y, Wiegand H, Dilzer SC, Lasseter KC: FTY720 pharmacokinetics in mild to moderate hepatic impairment. J Clin Pharmacol 2005;45:446-452.
30. Foller M, Sopjani M, Mahmud H, Lang F: Vanadate-induced suicidal erythrocyte death. Kidney Blood Press Res 2008;31:87-93.
31. Mahmud H, Foller M, Lang F: Arsenic-induced suicidal erythrocyte death. Arch Toxicol 2009;83:107-113.
32. Niemoeller OM, Foller M, Lang C, Huber SM, Lang F: Retinoic acid induced suicidal erythrocyte death. Cell Physiol Biochem 2008;21:193-202.
33. Niemoeller OM, Mahmud H, Foller M, Wieder T, Lang F: Ciglitazone and 15d-PGJ2 induced suicidal erythrocyte death. Cell Physiol Biochem 2008;22:237-244.
34. Sopjani M, Foller M, Lang F: Gold stimulates Ca2+ entry into and subsequent suicidal death of erythrocytes. Toxicology 2008;244:271-279.
35. Sopjani M, Foller M, Dreischer P, Lang F: Stimulation of eryptosis by cadmium ions. Cell Physiol Biochem 2008;22:245-252.
36. Sopjani M, Foller M, Gulbins E, Lang F: Suicidal death of erythrocytes due to selenium-compounds. Cell Physiol Biochem 2008;22:387-394.
37. Wang K, Mahmud H, Föller M, Biswas R, Lang KS, Bohn E, Goetz F, Lang F: Lipopeptides in the Triggering of Eryth-rocyte Cell Membrane Scrambling. Cell Physiol Biochem 2008;22:381-386.
38. Brand VB, Koka S, Lang C, Jendrossek V, Huber SM, Gulbins E, Lang F: Influence of Amitriptyline on Eryptosis, Para-sitemia and Survival of Plasmodium Berghei- Infected Mice. Cell Physiol Biochem 2008;22:405-412.
39. Koka S, Lang C, Boini KM, Bobbala D, Huber SM, Lang F: Influence of chlo-rpromazine on eryptosis, parasitemia and survival of Plasmodium berghe infected mice. Cell Physiol Biochem 2008;22:261-268.
40. Koka S, Lang C, Niemoeller OM, Boini KM, Nicolay J P, Huber SM, Lang F: Influence of NO synthase inhibitor L-NAME on parasitemia and survival of Plasmodium berghei infected mice. Cell Physiol Biochem 2008;21:481-488.
41. Fadok VA, Bratton DL, Rose DM, Pearson A, Ezekewitz RA, Henson PM: A receptor for phosphatidylserine-spe-cific clearance of apoptotic cells. Nature 2000;405:85-90.
42. Boas FE, Forman L, Beutler E: Phosphatidylserine exposure and red cell viability in red cell aging and in hemolytic anemia. Proc Natl Acad Sci \USA 1998;95:3077-3081.
43. Kempe DS, Lang PA, Duranton C, Akel A, Lang KS, Huber SM, Wieder T, Lang F: Enhanced programmed cell death of iron-deficient erythrocytes. FASEB J 2006;20:368-370.
44. Salvadori M, Budde K, Charpentier B, Klempnauer J, Nashan B, Pallardo LM, Eris J, Schena FP, Eisenberger U, Rostaing L, Hmissi A, Aradhye S: FTY720 versus MMF with cyclosporine in de novo renal transplantation: a 1-year, randomized controlled trial in Europe and Australasia. Am J Transplant 2006;6:2912-2921.
45. Andrews DA, Low PS: Role of red blood cells in thrombosis. Curr Opin Hematol 1999;6:76-82.
46. Closse C, Dachary-Prigent J, Boisseau MR: Phosphatidylserine-related adhesion of human erythrocytes to vascular en-dothelium. Br J Haematol 1999;107:300-302.
47. Gallagher PG, Chang SH, Rettig MP, Neely JE, Hillery CA, Smith BD, Low PS: Altered erythrocyte endothelial adherence and membrane phospholipid asymmetry in hereditary hydrocytosis. Blood 2003;101:4625-4627.
48. Pandolfi A, Di Pietro N, Sirolli V, Giardinelli A, Di Silvestre S, Amoroso L, Di Tomo P, Capani F, Consoli A, Bonomini M: Mechanisms of uremic erythrocyte-induced adhesion of human monocytes to cultured endothelial cells. J Cell Physiol 2007;213:699-709.
49. Wood BL, Gibson DF, Tait JF: Increased erythrocyte phosphatidylserine exposure in sickle cell disease: flow-cytometric measurement and clinical associations. Blood 1996;88:1873-1880.
50. Chung SM, Bae ON, Lim KM, Noh JY, Lee MY, Jung YS, Chung JH: Lysophosphatidic acid induces thrombo-genic activity through phosphatidyl-serine exposure and procoagulant microvesicle generation in human eryth-rocytes. Arterioscler Thromb Vasc Biol 2007;27:414-421.
51. Zwaal RF, Comfurius P, Bevers EM: Surface exposure of phosphatidylserine in pathological cells. Cell Mol Life Sci 2005;62:971-988.
52. Zappulla D: Environmental stress, eryth-rocyte dysfunctions, inflammation, and the metabolic syndrome: adaptations to CO2 increases? J Cardiometab Syndr 2008;3:30-34.